Formosa Pharmaceuticals Inc Sustainability Reports

Formosa Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing therapies in ophthalmology and oncology. The company utilizes its proprietary APNT nanotechnology platform to formulate advanced drug profiles.

Sector: Manufacturing

Country: Taiwan

Exchange: Taiwan Stock Exchange

FIGI: BBG00HDLSDS2

13 reports from 2019 to 2025

• Formosa Pharmaceuticals Inc 2025 Annual Report
• Formosa Pharmaceuticals Inc 2025 Consolidated Financial Statements and Independent Auditors' Review Report
• Formosa Pharmaceuticals Inc 2024 Individual Financial Report and Independent Auditor's Report
• Formosa Pharmaceuticals Inc 2024 Annual Report
• Formosa Pharmaceuticals Inc 2024 Sustainability Report